Summit Therapeutics Inc. (SMMT) Shareholders’ equity 2017–2024
Summit Therapeutics Inc. (SMMT) shareholders’ equity at each fiscal year-end, per SEC filings.
$388.7MFY2024 · since FY2017: -$3.6M → $388.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $388.7M | +400.4% |
| FY2023 | $77.7M | -38.7% |
| FY2022 | $126.7M | +52.1% |
| FY2021 | $83.3M | +4.8% |
| FY2020 | $79.5M | — |
| FY2018 | $57.6M | +1704.6% |
| FY2017 | -$3.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice